Zhengye Biotechnology Holding (ZYBT) Short-term Investments (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Short-term Investments of $219948.5 for Q4 2025, up 10.25% year-on-year from $199496.1 in Q4 2024, and down 22.0% on a QoQ basis from $282000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Short-term Investments (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Short-term Investments for 3 consecutive years, with $219948.5 the latest figure, recorded in Q4 2025.
- Quarterly Short-term Investments rose 10.25% year-over-year to $219948.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $219948.5 (up 10.25% YoY) and the FY2025 annual result came in at $223000.0, up 11.78% from the prior year.
- Short-term Investments retreated to $219948.5 in Q4 2025 per ZYBT's latest filing, from $282000.0 in the prior quarter.
- Over the last five years, Short-term Investments for ZYBT reached as high as $1.7 million in Q4 2023 and fell as low as $199496.1 in Q4 2024.
- A 3-year average of $595946.9 and a median of $250974.2 in 2025 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments slumped 88.14% — and 2025, when it climbed 10.25%.
- Year by year, Short-term Investments stood at $1.7 million in 2023, then sank by 88.14% to $199496.1 in 2024, then rose by 10.25% to $219948.5 in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $219948.5, $282000.0, and $199496.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Zhengye Biotechnology Holding | 69.50 Mn | 62.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 219,948.46 |
| Jun 30, 2025 | 282,000.00 |
| Dec 31, 2024 | 199,496.13 |
| Dec 31, 2023 | 1.68 Mn |